PIPELINE 

We are focused on becoming a global leader in the development of molecularly-targeted drugs and combination therapies to treat chronic liver diseases and liver cancer.

 
pipeline-2.jpg

NASH


PRIMARY BILIARY CHOLANGITIS

B.jpg

ONCOLOGY